Treatment at Penn
The Penn Myasthenia Gravis and Thymoma Program was developed to treat patients with myasthenia gravis (MG) and thymoma, which are often comorbid disorders. Because these diseases are related and can be complicated to treat, they require multiple specialists. We created the program to coordinate care across specialties in the management of these patients. The team is comprised of neurologists, thoracic surgeons, radiologists, ophthalmologists and many others specialists, who together will develop a comprehensive treatment plan for your condition.
To improve the muscle weakness caused by myasthenia gravis, we provide medicines to suppress the immune system. In addition to pills, there are several kinds of emergency treatments that are available for people who are short of breath or are having trouble swallowing. These include intravenous gamma globulin (IVIG) and plasma pheresis. At Penn, we also have clinical trials for patients with a severe disease who are not responding to conventional treatments.
Treatment for thymomas is centered around their removal. If the tumor has not invaded the capsule, surgery is usually the only treatment recommended. For locally advanced cases, we may consider radiation therapy or chemotherapy plus radiation therapy after surgery. In the less common circumstance of a thymoma that does not appear to be completely removable, we may do chemotherapy first, followed by surgery and then radiation therapy. Rarely, thymic tumors can metastasize (spread to other sites), in which case chemotherapy is the mainstay of treatment.
Thymic hyperplasia by itself does not require any treatment, but the associated conditions, such as hyperthyroidism, may. In patients with MG and thymic hyperplasia, we will probably recommend surgery to remove the thymus gland.
If radiation therapy is included in the treatment plans, there are various types of radiation therapy available at Penn. Proton beam therapy, housed at the Roberts Proton Therapy Center at Penn, is a special type of radiation that is extremely precise: When it enters the body, it targets just the area where the thymoma was but spares the healthy, normal surrounding tissue, such as the heart and lungs.
The Roberts Proton Therapy Center is one of the few in the world to use pencil beam scanning, technology that "paints" the tumor and is ideal for complex targets located near critical structures, like thymomas. For this reason, proton therapy can result in fewer side effects both during the time that a patient receives radiation and years afterwards.